Originally published In Press as doi:10.1074/mcp.M600407-MCP200 on January 6, 2007.
Molecular & Cellular Proteomics 6:638-647, 2007.
© 2007 by The American Society for Biochemistry and Molecular Biology, Inc.
Research
Rapid and Individual-specific Glycoprofiling of the Low Abundance N-Glycosylated Protein Tissue Inhibitor of Metalloproteinases-1*,S
Morten Thaysen-Andersen ,
Ida B. Thøgersen ,
Hans Jørgen Nielsen¶,
Ulrik Lademann||,
Nils Brünner||,
Jan J. Enghild and
Peter Højrup ,**
From the Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark, Department of Molecular Biology, University of Aarhus, DK-8000 Aarhus C, Denmark, ¶ Department of Surgical Gastroenterology, Hvidovre University Hospital, DK-2650 Hvidovre, Denmark, and || Institute of Veterinary Pathobiology, The Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C, Copenhagen, Denmark
A gel-based method for a mass spectrometric site-specific glycoanalysis was developed using a recombinant glycoprotein expressed in two different cell lines. Hydrophilic interaction liquid chromatography at nanoscale level was used to enrich for glycopeptides prior to MS. The glycoprofiling was performed using matrix-assisted laser desorption/ionization MS and MS/MS. The method proved to be fast and sensitive and furthermore yielded a comprehensive site-specific glycan analysis, allowing a differentiation of the glycoprofiles of the two sources of recombinant protein, both comprising N-glycans of a highly heterogeneous nature. To test the potential of the method, tissue inhibitor of metalloproteinases-1 (TIMP-1), a secreted low abundance N-glycosylated protein and a cancer marker, was purified in an individual-specific manner from plasma of five healthy individuals using IgG depletion and immunoaffinity chromatography. The corresponding TIMP-1 glycoprofiles were determined to be highly similar, comprising mainly bi- and triantennary complex oligosaccharides. Additionally it was shown that platelet-derived TIMP-1 displayed a similar glycoprofile. This is the first study to investigate the glycosylation of naturally occurring human TIMP-1, and the high similarity of the glycoprofiles showed that individual-specific glycosylation variations of TIMP-1 are minimal. In addition, the results showed that TIMP-1 derived from platelets and plasma is similarly glycosylated. This comprehensive and rapid glycoprofiling of a low abundance glycoprotein performed in an individual-specific manner allows for future studies of glycosylated biomarkers for person-specific detection of altered glycosylation and may thus allow early detection and monitoring of diseases.
** To whom correspondence should be addressed. Tel.: 45-6550-2371; Fax: 45-6550-2467; E-mail: php{at}bmb.sdu.dk

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Dissing-Olesen, M. Thaysen-Andersen, M. Meldgaard, P. Hojrup, and B. Finsen
The Function of the Human Interferon-{beta}1a Glycan Determined in Vivo
J. Pharmacol. Exp. Ther.,
July 1, 2008;
326(1):
338 - 347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-S. Kim, S. Y. Hwang, H.-Y. Kang, H. Sohn, S. Oh, J.-Y. Kim, J. S. Yoo, Y. H. Kim, C.-H. Kim, J.-H. Jeon, et al.
Functional Proteomics Study Reveals That N-Acetylglucosaminyltransferase V Reinforces the Invasive/Metastatic Potential of Colon Cancer through Aberrant Glycosylation on Tissue Inhibitor of Metalloproteinase-
Mol. Cell. Proteomics,
January 1, 2008;
7(1):
1 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|